Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47395)
CDC/NIH Web Information Database (32192)
CDC-Authored Genomics and Precision Health Publications Database (6062)
Precision Health Database (63770)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26823)
All of Us Reports and Publications Database (681)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226753)
Epigenetic Epidemiology Publications Database (22811)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Pharmacogenomics
Last data update: May 03, 2024
. (Total: 63770 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 138 Records)
Next
Query Trace:
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective.
A L Peters et al. Breast 2024 75103728
Similar articles in PubMed
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Beverly Kyalwazi et al. JAMA Netw Open 2023 6(12) e2349646
Similar articles in PubMed
A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer.
Kwang Hyun Yoon et al. Ann Surg Treat Res 2023 105(6) 360-368
Similar articles in PubMed
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
Reshma Jagsi et al. J Clin Oncol 2023 JCO2302270
Similar articles in PubMed
Nomogram Update to Predict the High Genomic Risk Breast Cancer by Different Races.
Peng Wu et al. Clin Breast Cancer 2023
Similar articles in PubMed
Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers.
Jing Wang et al. Breast Cancer Res Treat 2023
Similar articles in PubMed
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer.
Slavica Janeva et al. Breast cancer research : BCR 2023 25(1) 36
Similar articles in PubMed
Bioinformatics combined with clinical data to analyze clinical characteristics and prognosis in patients with HER2 low expression breast cancer.
Yongcheng Chen et al. Gland surgery 2023 12(2) 197-207
Similar articles in PubMed
Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes.
Guan-Qiao Li et al. Frontiers in endocrinology 2023 141103949
Similar articles in PubMed
Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.
Akina Seki et al. Breast disease 2023 42(1) 5-15
Similar articles in PubMed
Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review.
Serena Bertozzi et al. Journal of clinical medicine 2023 12(4)
Similar articles in PubMed
Adjuvant Chemotherapy De-Escalation with Genomic Assay Protocol in Patients with Early Breast Cancer: A Single-Centre Prospective Cohort Study.
Diogo Martins-Branco et al. Acta medica portuguesa 2023
Similar articles in PubMed
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
Subarnarekha Chatterji et al. The Lancet. Oncology 2023 24(2) e74-e85
Similar articles in PubMed
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Waissengrin B et al. ESMO open 2022 7(6) 100648
Similar articles in PubMed
Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age.
Williams Austin D et al. Breast cancer research and treatment 2022
Similar articles in PubMed
Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.
ElNaggar Adam et al. Gynecologic oncology 2022
Similar articles in PubMed
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.
Patel Rima et al. Cancer 2022
Similar articles in PubMed
A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©.
Davey Matthew G et al. Journal of personalized medicine 2022 12(7)
Similar articles in PubMed
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
Hassan Saima et al. The oncologist 2022
Similar articles in PubMed
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy.
Sella Tal et al. Breast cancer research and treatment 2022
Similar articles in PubMed
Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer.
Min Yu et al. Frontiers in endocrinology 2022 13824362
Similar articles in PubMed
Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.
Shanmugalingam Aswin et al. Breast cancer research and treatment 2022
Similar articles in PubMed
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
Layman Rachel M et al. Cancer medicine 2022
Similar articles in PubMed
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.
et al. JAMA oncology 2022
Similar articles in PubMed
Can Multigene Testing Provide Additional Risk Stratification for Patients Considered Eligible for Accelerated Partial Breast Irradiation?
Pawloski K R et al. International journal of radiation oncology, biology, physics 2021 111(3S) e208-e209
Similar articles in PubMed
Identifying Clinicopathological Factors Associated with Oncotype DX 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada.
Gagnet Simon et al. Journal of personalized medicine 2021 11(9)
Similar articles in PubMed
Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer.
Kurian Allison W et al. Journal of the National Cancer Institute 2021
Similar articles in PubMed
Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials.
Xu Yaqian et al. EClinicalMedicine 2021 38101031
Similar articles in PubMed
Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer.
Yamamoto Shinya et al. In vivo (Athens, Greece) 2021 35(4) 2439-2444
Similar articles in PubMed
Recurrence score testing does not appear to benefit patients with Grade 1, progesterone receptor-positive breast cancers: An opportunity to eliminate overtreatment and decrease testing costs.
Sibia Udai S et al. Hematology/oncology and stem cell therapy 2021
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
May 03, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP